Open original FDA record ↗Recall record
- FDA identifier
- Z-2562-2021
- Company in FDA record
- Lymol Medical Corporation
- FDA record creation date
- Sep 24, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Reprocessing instructions were revised November 15, 2020, to reflect new processes and equipment used at consignee user facilities. New instructions were not sent to all consignees of the devices at the time of the revision.
Source facts
- Action
- On August 9, 2021, the firm began notifying all consignees via email that the reprocessing instructions have changed. Included with each notification is a copy of the Urgent Notice, the revised IFU, and a response form. Customers were advised that the sterilization procedures were updated on November 15, 2020. Customers should discard and replace the obsolete procedures with the revised procedures included with the firm's mailing. The revised instructions have been uploaded to the LYMOL website at https://www.lymolmedical.com/instructions.cfm Customers with questions may contact the firm at Kabrano@lymolmedical.com.
- Initiated
- 2021-07-29
- Root cause
- Under Investigation by firm
- Terminated
- 2022-10-04
- Distribution
- US Nationwide distribution.
- Recall number
- Z-2562-2021
- Recall status
- Terminated
- CDRH record ID
- 188774
- FDA record created
- 2021-09-24
- Recall event number
- 88485